nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A4—larynx—esophageal cancer	0.049	0.281	CbGeAlD
Tiotropium—CHRM3—exocrine gland—esophageal cancer	0.016	0.0919	CbGeAlD
Tiotropium—SLC22A4—neck—esophageal cancer	0.013	0.0744	CbGeAlD
Tiotropium—CHRM5—epithelium—esophageal cancer	0.0125	0.0715	CbGeAlD
Tiotropium—Ileus paralytic—Capecitabine—esophageal cancer	0.0114	0.0262	CcSEcCtD
Tiotropium—Hoarseness—Capecitabine—esophageal cancer	0.0112	0.0258	CcSEcCtD
Tiotropium—Disorder sight—Capecitabine—esophageal cancer	0.0103	0.0238	CcSEcCtD
Tiotropium—Joint swelling—Capecitabine—esophageal cancer	0.01	0.0231	CcSEcCtD
Tiotropium—SLC22A4—bronchus—esophageal cancer	0.0087	0.0499	CbGeAlD
Tiotropium—Infection—Carboplatin—esophageal cancer	0.00805	0.0186	CcSEcCtD
Tiotropium—Ulcerative stomatitis—Methotrexate—esophageal cancer	0.00792	0.0183	CcSEcCtD
Tiotropium—SLC22A4—trachea—esophageal cancer	0.00781	0.0448	CbGeAlD
Tiotropium—Oral candidiasis—Capecitabine—esophageal cancer	0.00773	0.0178	CcSEcCtD
Tiotropium—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.0075	0.0173	CcSEcCtD
Tiotropium—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00728	0.0168	CcSEcCtD
Tiotropium—Intestinal obstruction—Capecitabine—esophageal cancer	0.00721	0.0166	CcSEcCtD
Tiotropium—Laryngeal pain—Capecitabine—esophageal cancer	0.00721	0.0166	CcSEcCtD
Tiotropium—CHRM1—trachea—esophageal cancer	0.00689	0.0395	CbGeAlD
Tiotropium—Laryngitis—Capecitabine—esophageal cancer	0.00682	0.0157	CcSEcCtD
Tiotropium—CHRM3—smooth muscle tissue—esophageal cancer	0.00672	0.0385	CbGeAlD
Tiotropium—SLC22A4—digestive system—esophageal cancer	0.00672	0.0385	CbGeAlD
Tiotropium—Herpes zoster—Capecitabine—esophageal cancer	0.00653	0.0151	CcSEcCtD
Tiotropium—Skin ulcer—Capecitabine—esophageal cancer	0.00631	0.0146	CcSEcCtD
Tiotropium—Dysphonia—Capecitabine—esophageal cancer	0.00597	0.0138	CcSEcCtD
Tiotropium—SLC22A5—bronchus—esophageal cancer	0.00576	0.033	CbGeAlD
Tiotropium—SLC22A4—lung—esophageal cancer	0.00561	0.0322	CbGeAlD
Tiotropium—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00544	0.0126	CcSEcCtD
Tiotropium—CHRM3—digestive system—esophageal cancer	0.00531	0.0304	CbGeAlD
Tiotropium—SLC22A5—trachea—esophageal cancer	0.00517	0.0296	CbGeAlD
Tiotropium—Cataract—Capecitabine—esophageal cancer	0.00516	0.0119	CcSEcCtD
Tiotropium—Bone pain—Capecitabine—esophageal cancer	0.00513	0.0118	CcSEcCtD
Tiotropium—CHRM1—lung—esophageal cancer	0.00495	0.0284	CbGeAlD
Tiotropium—Herpes zoster—Methotrexate—esophageal cancer	0.00486	0.0112	CcSEcCtD
Tiotropium—Influenza like illness—Capecitabine—esophageal cancer	0.00477	0.011	CcSEcCtD
Tiotropium—Skin ulcer—Methotrexate—esophageal cancer	0.0047	0.0108	CcSEcCtD
Tiotropium—Candida infection—Capecitabine—esophageal cancer	0.00469	0.0108	CcSEcCtD
Tiotropium—Gingivitis—Methotrexate—esophageal cancer	0.00466	0.0108	CcSEcCtD
Tiotropium—Dehydration—Cisplatin—esophageal cancer	0.0045	0.0104	CcSEcCtD
Tiotropium—SLC22A5—digestive system—esophageal cancer	0.00445	0.0255	CbGeAlD
Tiotropium—Mouth ulceration—Capecitabine—esophageal cancer	0.00444	0.0102	CcSEcCtD
Tiotropium—Glossitis—Methotrexate—esophageal cancer	0.00397	0.00916	CcSEcCtD
Tiotropium—SLC22A4—lymph node—esophageal cancer	0.00384	0.022	CbGeAlD
Tiotropium—SLC22A5—lung—esophageal cancer	0.00371	0.0213	CbGeAlD
Tiotropium—Arthritis—Capecitabine—esophageal cancer	0.00367	0.00847	CcSEcCtD
Tiotropium—Renal failure—Cisplatin—esophageal cancer	0.00367	0.00846	CcSEcCtD
Tiotropium—Stomatitis—Cisplatin—esophageal cancer	0.00363	0.00839	CcSEcCtD
Tiotropium—Pain in extremity—Capecitabine—esophageal cancer	0.00357	0.00823	CcSEcCtD
Tiotropium—Urinary retention—Capecitabine—esophageal cancer	0.00339	0.00782	CcSEcCtD
Tiotropium—Dehydration—Capecitabine—esophageal cancer	0.00332	0.00765	CcSEcCtD
Tiotropium—Mouth ulceration—Methotrexate—esophageal cancer	0.00331	0.00763	CcSEcCtD
Tiotropium—Urinary tract disorder—Cisplatin—esophageal cancer	0.00331	0.00763	CcSEcCtD
Tiotropium—Connective tissue disorder—Cisplatin—esophageal cancer	0.00329	0.00759	CcSEcCtD
Tiotropium—Urethral disorder—Cisplatin—esophageal cancer	0.00328	0.00757	CcSEcCtD
Tiotropium—Dry skin—Capecitabine—esophageal cancer	0.00327	0.00754	CcSEcCtD
Tiotropium—Visual impairment—Cisplatin—esophageal cancer	0.00323	0.00744	CcSEcCtD
Tiotropium—Eye disorder—Cisplatin—esophageal cancer	0.00313	0.00722	CcSEcCtD
Tiotropium—Dysphagia—Capecitabine—esophageal cancer	0.00308	0.00711	CcSEcCtD
Tiotropium—Immune system disorder—Cisplatin—esophageal cancer	0.00302	0.00698	CcSEcCtD
Tiotropium—Mediastinal disorder—Cisplatin—esophageal cancer	0.00302	0.00696	CcSEcCtD
Tiotropium—Angina pectoris—Capecitabine—esophageal cancer	0.003	0.00693	CcSEcCtD
Tiotropium—Arrhythmia—Cisplatin—esophageal cancer	0.00299	0.0069	CcSEcCtD
Tiotropium—CYP3A4—digestive system—esophageal cancer	0.00292	0.0167	CbGeAlD
Tiotropium—Malnutrition—Cisplatin—esophageal cancer	0.00291	0.00672	CcSEcCtD
Tiotropium—Dysuria—Capecitabine—esophageal cancer	0.00288	0.00665	CcSEcCtD
Tiotropium—CYP2D6—digestive system—esophageal cancer	0.00287	0.0165	CbGeAlD
Tiotropium—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00287	0.00661	CcSEcCtD
Tiotropium—Hyperglycaemia—Capecitabine—esophageal cancer	0.00278	0.00642	CcSEcCtD
Tiotropium—Vision blurred—Cisplatin—esophageal cancer	0.00275	0.00634	CcSEcCtD
Tiotropium—Renal failure—Capecitabine—esophageal cancer	0.0027	0.00623	CcSEcCtD
Tiotropium—Stomatitis—Capecitabine—esophageal cancer	0.00268	0.00618	CcSEcCtD
Tiotropium—Urinary tract infection—Capecitabine—esophageal cancer	0.00267	0.00616	CcSEcCtD
Tiotropium—Epistaxis—Capecitabine—esophageal cancer	0.00259	0.00598	CcSEcCtD
Tiotropium—SLC22A5—lymph node—esophageal cancer	0.00254	0.0146	CbGeAlD
Tiotropium—Myalgia—Cisplatin—esophageal cancer	0.00248	0.00572	CcSEcCtD
Tiotropium—Rhinitis—Capecitabine—esophageal cancer	0.00247	0.00571	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00246	0.00568	CcSEcCtD
Tiotropium—Pharyngitis—Capecitabine—esophageal cancer	0.00245	0.00565	CcSEcCtD
Tiotropium—Urinary tract disorder—Capecitabine—esophageal cancer	0.00244	0.00562	CcSEcCtD
Tiotropium—Oedema peripheral—Capecitabine—esophageal cancer	0.00243	0.00561	CcSEcCtD
Tiotropium—Connective tissue disorder—Capecitabine—esophageal cancer	0.00242	0.00559	CcSEcCtD
Tiotropium—Urethral disorder—Capecitabine—esophageal cancer	0.00242	0.00558	CcSEcCtD
Tiotropium—Oedema—Cisplatin—esophageal cancer	0.00238	0.00549	CcSEcCtD
Tiotropium—Visual impairment—Capecitabine—esophageal cancer	0.00238	0.00549	CcSEcCtD
Tiotropium—Infection—Cisplatin—esophageal cancer	0.00236	0.00545	CcSEcCtD
Tiotropium—Nervous system disorder—Cisplatin—esophageal cancer	0.00233	0.00538	CcSEcCtD
Tiotropium—Tachycardia—Cisplatin—esophageal cancer	0.00232	0.00535	CcSEcCtD
Tiotropium—Skin disorder—Cisplatin—esophageal cancer	0.00231	0.00533	CcSEcCtD
Tiotropium—Eye disorder—Capecitabine—esophageal cancer	0.00231	0.00532	CcSEcCtD
Tiotropium—Angiopathy—Capecitabine—esophageal cancer	0.00224	0.00516	CcSEcCtD
Tiotropium—Immune system disorder—Capecitabine—esophageal cancer	0.00223	0.00514	CcSEcCtD
Tiotropium—Mediastinal disorder—Capecitabine—esophageal cancer	0.00222	0.00513	CcSEcCtD
Tiotropium—Arrhythmia—Capecitabine—esophageal cancer	0.0022	0.00509	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00217	0.005	CcSEcCtD
Tiotropium—Mental disorder—Capecitabine—esophageal cancer	0.00216	0.00499	CcSEcCtD
Tiotropium—Malnutrition—Capecitabine—esophageal cancer	0.00215	0.00496	CcSEcCtD
Tiotropium—Dysuria—Methotrexate—esophageal cancer	0.00215	0.00495	CcSEcCtD
Tiotropium—Paraesthesia—Cisplatin—esophageal cancer	0.00214	0.00493	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00213	0.00492	CcSEcCtD
Tiotropium—Back pain—Capecitabine—esophageal cancer	0.00208	0.00479	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00205	0.00474	CcSEcCtD
Tiotropium—Vision blurred—Capecitabine—esophageal cancer	0.00202	0.00467	CcSEcCtD
Tiotropium—Renal failure—Methotrexate—esophageal cancer	0.00201	0.00464	CcSEcCtD
Tiotropium—Stomatitis—Methotrexate—esophageal cancer	0.00199	0.0046	CcSEcCtD
Tiotropium—Epistaxis—Methotrexate—esophageal cancer	0.00193	0.00445	CcSEcCtD
Tiotropium—Syncope—Capecitabine—esophageal cancer	0.00193	0.00444	CcSEcCtD
Tiotropium—Palpitations—Capecitabine—esophageal cancer	0.0019	0.00438	CcSEcCtD
Tiotropium—Loss of consciousness—Capecitabine—esophageal cancer	0.00189	0.00436	CcSEcCtD
Tiotropium—Cough—Capecitabine—esophageal cancer	0.00187	0.00432	CcSEcCtD
Tiotropium—Hypertension—Capecitabine—esophageal cancer	0.00185	0.00428	CcSEcCtD
Tiotropium—Chest pain—Capecitabine—esophageal cancer	0.00183	0.00422	CcSEcCtD
Tiotropium—Arthralgia—Capecitabine—esophageal cancer	0.00183	0.00422	CcSEcCtD
Tiotropium—Myalgia—Capecitabine—esophageal cancer	0.00183	0.00422	CcSEcCtD
Tiotropium—Pharyngitis—Methotrexate—esophageal cancer	0.00182	0.00421	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00182	0.00419	CcSEcCtD
Tiotropium—Urinary tract disorder—Methotrexate—esophageal cancer	0.00181	0.00419	CcSEcCtD
Tiotropium—Urethral disorder—Methotrexate—esophageal cancer	0.0018	0.00415	CcSEcCtD
Tiotropium—Dry mouth—Capecitabine—esophageal cancer	0.00179	0.00413	CcSEcCtD
Tiotropium—Visual impairment—Methotrexate—esophageal cancer	0.00177	0.00408	CcSEcCtD
Tiotropium—Oedema—Capecitabine—esophageal cancer	0.00175	0.00404	CcSEcCtD
Tiotropium—Hypersensitivity—Cisplatin—esophageal cancer	0.00175	0.00404	CcSEcCtD
Tiotropium—Infection—Capecitabine—esophageal cancer	0.00174	0.00402	CcSEcCtD
Tiotropium—Shock—Capecitabine—esophageal cancer	0.00172	0.00398	CcSEcCtD
Tiotropium—Nervous system disorder—Capecitabine—esophageal cancer	0.00172	0.00397	CcSEcCtD
Tiotropium—Eye disorder—Methotrexate—esophageal cancer	0.00172	0.00396	CcSEcCtD
Tiotropium—Tachycardia—Capecitabine—esophageal cancer	0.00171	0.00395	CcSEcCtD
Tiotropium—Skin disorder—Capecitabine—esophageal cancer	0.0017	0.00393	CcSEcCtD
Tiotropium—Angiopathy—Methotrexate—esophageal cancer	0.00167	0.00384	CcSEcCtD
Tiotropium—Immune system disorder—Methotrexate—esophageal cancer	0.00166	0.00383	CcSEcCtD
Tiotropium—Mediastinal disorder—Methotrexate—esophageal cancer	0.00166	0.00382	CcSEcCtD
Tiotropium—Mental disorder—Methotrexate—esophageal cancer	0.00161	0.00371	CcSEcCtD
Tiotropium—Malnutrition—Methotrexate—esophageal cancer	0.0016	0.00369	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0016	0.00368	CcSEcCtD
Tiotropium—Insomnia—Capecitabine—esophageal cancer	0.00159	0.00366	CcSEcCtD
Tiotropium—Paraesthesia—Capecitabine—esophageal cancer	0.00157	0.00363	CcSEcCtD
Tiotropium—Back pain—Methotrexate—esophageal cancer	0.00155	0.00357	CcSEcCtD
Tiotropium—Dyspepsia—Capecitabine—esophageal cancer	0.00154	0.00356	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00151	0.00349	CcSEcCtD
Tiotropium—Vomiting—Cisplatin—esophageal cancer	0.00151	0.00349	CcSEcCtD
Tiotropium—Vision blurred—Methotrexate—esophageal cancer	0.00151	0.00348	CcSEcCtD
Tiotropium—Rash—Cisplatin—esophageal cancer	0.0015	0.00346	CcSEcCtD
Tiotropium—Constipation—Capecitabine—esophageal cancer	0.0015	0.00346	CcSEcCtD
Tiotropium—Dermatitis—Cisplatin—esophageal cancer	0.0015	0.00346	CcSEcCtD
Tiotropium—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00143	0.00331	CcSEcCtD
Tiotropium—Nausea—Cisplatin—esophageal cancer	0.00141	0.00326	CcSEcCtD
Tiotropium—Cough—Methotrexate—esophageal cancer	0.0014	0.00322	CcSEcCtD
Tiotropium—Urticaria—Capecitabine—esophageal cancer	0.00139	0.00321	CcSEcCtD
Tiotropium—Abdominal pain—Capecitabine—esophageal cancer	0.00139	0.0032	CcSEcCtD
Tiotropium—Arthralgia—Methotrexate—esophageal cancer	0.00136	0.00314	CcSEcCtD
Tiotropium—Myalgia—Methotrexate—esophageal cancer	0.00136	0.00314	CcSEcCtD
Tiotropium—Chest pain—Methotrexate—esophageal cancer	0.00136	0.00314	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00135	0.00312	CcSEcCtD
Tiotropium—Infection—Methotrexate—esophageal cancer	0.0013	0.00299	CcSEcCtD
Tiotropium—Hypersensitivity—Capecitabine—esophageal cancer	0.00129	0.00298	CcSEcCtD
Tiotropium—Nervous system disorder—Methotrexate—esophageal cancer	0.00128	0.00295	CcSEcCtD
Tiotropium—Skin disorder—Methotrexate—esophageal cancer	0.00127	0.00292	CcSEcCtD
Tiotropium—Pruritus—Capecitabine—esophageal cancer	0.00124	0.00286	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00119	0.00274	CcSEcCtD
Tiotropium—Insomnia—Methotrexate—esophageal cancer	0.00118	0.00272	CcSEcCtD
Tiotropium—Paraesthesia—Methotrexate—esophageal cancer	0.00117	0.0027	CcSEcCtD
Tiotropium—Dizziness—Capecitabine—esophageal cancer	0.00116	0.00267	CcSEcCtD
Tiotropium—Dyspepsia—Methotrexate—esophageal cancer	0.00115	0.00265	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00113	0.0026	CcSEcCtD
Tiotropium—Vomiting—Capecitabine—esophageal cancer	0.00111	0.00257	CcSEcCtD
Tiotropium—Rash—Capecitabine—esophageal cancer	0.00111	0.00255	CcSEcCtD
Tiotropium—Dermatitis—Capecitabine—esophageal cancer	0.0011	0.00255	CcSEcCtD
Tiotropium—Headache—Capecitabine—esophageal cancer	0.0011	0.00253	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00107	0.00246	CcSEcCtD
Tiotropium—Nausea—Capecitabine—esophageal cancer	0.00104	0.0024	CcSEcCtD
Tiotropium—Urticaria—Methotrexate—esophageal cancer	0.00104	0.00239	CcSEcCtD
Tiotropium—Abdominal pain—Methotrexate—esophageal cancer	0.00103	0.00238	CcSEcCtD
Tiotropium—Hypersensitivity—Methotrexate—esophageal cancer	0.000961	0.00222	CcSEcCtD
Tiotropium—Pruritus—Methotrexate—esophageal cancer	0.000923	0.00213	CcSEcCtD
Tiotropium—Dizziness—Methotrexate—esophageal cancer	0.000863	0.00199	CcSEcCtD
Tiotropium—Vomiting—Methotrexate—esophageal cancer	0.00083	0.00191	CcSEcCtD
Tiotropium—Rash—Methotrexate—esophageal cancer	0.000823	0.0019	CcSEcCtD
Tiotropium—Dermatitis—Methotrexate—esophageal cancer	0.000822	0.0019	CcSEcCtD
Tiotropium—Headache—Methotrexate—esophageal cancer	0.000818	0.00189	CcSEcCtD
Tiotropium—Nausea—Methotrexate—esophageal cancer	0.000775	0.00179	CcSEcCtD
Tiotropium—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	0.000222	0.000565	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—SST—esophageal cancer	0.000221	0.000565	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—SST—esophageal cancer	0.000221	0.000563	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP26A1—esophageal cancer	0.00022	0.00056	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.000219	0.00056	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000219	0.000557	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000216	0.00055	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000215	0.000548	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000214	0.000546	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000213	0.000543	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GNG7—esophageal cancer	0.000212	0.00054	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000209	0.000532	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.000208	0.00053	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000207	0.000527	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000206	0.000525	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000206	0.000525	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTO1—esophageal cancer	0.000204	0.000521	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—TPI1—esophageal cancer	0.000204	0.000521	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000204	0.00052	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000201	0.000513	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.0002	0.000511	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000198	0.000506	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—XIAP—esophageal cancer	0.000198	0.000506	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000198	0.000504	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000197	0.000503	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000196	0.0005	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALDOB—esophageal cancer	0.000196	0.000499	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000195	0.000498	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PFN1—esophageal cancer	0.000195	0.000498	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000195	0.000496	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.000193	0.000493	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.000193	0.000491	CbGpPWpGaD
Tiotropium—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000192	0.00049	CbGpPWpGaD
Tiotropium—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000191	0.000488	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.00019	0.000483	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CA1—esophageal cancer	0.00019	0.000483	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000188	0.000481	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CTNNA1—esophageal cancer	0.000188	0.000478	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CRABP1—esophageal cancer	0.000187	0.000476	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL2—esophageal cancer	0.000186	0.000476	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GNG7—esophageal cancer	0.000178	0.000453	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000175	0.000447	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	0.000175	0.000447	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	0.000175	0.000446	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PSME1—esophageal cancer	0.000174	0.000444	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PSME2—esophageal cancer	0.000174	0.000444	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ANXA1—esophageal cancer	0.000173	0.000442	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CA2—esophageal cancer	0.000173	0.000442	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.000173	0.000441	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000172	0.000438	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000171	0.000437	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000171	0.000436	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.000171	0.000436	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000169	0.000431	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SST—esophageal cancer	0.000169	0.00043	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000166	0.000425	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOTCH3—esophageal cancer	0.000164	0.000419	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GHRL—esophageal cancer	0.000164	0.000419	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—FBXW7—esophageal cancer	0.000162	0.000412	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000161	0.000411	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000161	0.000411	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTT1—esophageal cancer	0.000158	0.000404	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000158	0.000403	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000158	0.000402	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000157	0.0004	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.000157	0.000399	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.000156	0.000398	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000156	0.000398	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000155	0.000394	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000149	0.00038	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.000149	0.000379	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ENO1—esophageal cancer	0.000148	0.000378	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS1—esophageal cancer	0.000148	0.000378	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOTCH2—esophageal cancer	0.000147	0.000376	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000147	0.000375	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PSME1—esophageal cancer	0.000146	0.000373	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PSME2—esophageal cancer	0.000146	0.000373	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000146	0.000372	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000146	0.000372	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000141	0.00036	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.00014	0.000356	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000139	0.000355	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000138	0.000352	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000135	0.000344	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000132	0.000337	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.000132	0.000336	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000131	0.000335	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000131	0.000335	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000131	0.000334	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFBR2—esophageal cancer	0.000131	0.000334	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.00013	0.000332	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.00013	0.000331	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000128	0.000326	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000126	0.000322	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CA1—esophageal cancer	0.000124	0.000316	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000124	0.000316	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SMAD4—esophageal cancer	0.000124	0.000316	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.000123	0.000313	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.000123	0.000313	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.000122	0.000312	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.000122	0.000312	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000122	0.000311	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000122	0.000311	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000122	0.000311	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000122	0.00031	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.000121	0.000309	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.000121	0.000309	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.000121	0.000307	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SST—esophageal cancer	0.000119	0.000303	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.000119	0.000303	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SST—esophageal cancer	0.000118	0.000302	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000117	0.000299	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000117	0.000299	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000116	0.000295	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.000116	0.000295	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	0.000115	0.000294	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GHRL—esophageal cancer	0.000115	0.000294	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	0.000114	0.000291	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GHRL—esophageal cancer	0.000114	0.000291	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000114	0.00029	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	0.000113	0.000289	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CA2—esophageal cancer	0.000113	0.000289	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000113	0.000287	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	0.000112	0.000287	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000112	0.000285	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—HMOX1—esophageal cancer	0.000108	0.000276	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000106	0.000271	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000105	0.000269	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000105	0.000269	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ABCB1—esophageal cancer	0.000104	0.000265	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000104	0.000265	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	0.000103	0.000264	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	0.000102	0.000261	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	0.000101	0.000258	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALDH2—esophageal cancer	9.96e-05	0.000254	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KDR—esophageal cancer	9.69e-05	0.000247	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTT1—esophageal cancer	9.47e-05	0.000241	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP2A6—esophageal cancer	9.36e-05	0.000239	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADH1B—esophageal cancer	9.24e-05	0.000236	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	9.21e-05	0.000235	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	9.18e-05	0.000234	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	9.13e-05	0.000233	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	9.09e-05	0.000232	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ENO1—esophageal cancer	8.87e-05	0.000226	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS1—esophageal cancer	8.87e-05	0.000226	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TYMP—esophageal cancer	8.83e-05	0.000225	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSME2—esophageal cancer	8.74e-05	0.000223	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSME1—esophageal cancer	8.74e-05	0.000223	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	8.72e-05	0.000222	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	8.69e-05	0.000222	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	8.6e-05	0.000219	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.59e-05	0.000219	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALOX15—esophageal cancer	8.37e-05	0.000213	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	8.27e-05	0.000211	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	8.13e-05	0.000207	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TPI1—esophageal cancer	7.98e-05	0.000204	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.98e-05	0.000204	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	7.77e-05	0.000198	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.65e-05	0.000195	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1B1—esophageal cancer	7.54e-05	0.000192	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOS3—esophageal cancer	7.41e-05	0.000189	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GAPDH—esophageal cancer	7.37e-05	0.000188	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CRABP1—esophageal cancer	7.3e-05	0.000186	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	7.13e-05	0.000182	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	7.11e-05	0.000181	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP19A1—esophageal cancer	7.09e-05	0.000181	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	7.06e-05	0.00018	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	7.04e-05	0.00018	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GNG7—esophageal cancer	6.95e-05	0.000177	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CREBBP—esophageal cancer	6.94e-05	0.000177	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	6.93e-05	0.000177	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KDR—esophageal cancer	6.82e-05	0.000174	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KDR—esophageal cancer	6.8e-05	0.000173	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KDR—esophageal cancer	6.73e-05	0.000172	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.51e-05	0.000166	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMOX1—esophageal cancer	6.47e-05	0.000165	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	6.43e-05	0.000164	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	6.4e-05	0.000163	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	6.34e-05	0.000162	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NOS3—esophageal cancer	6.22e-05	0.000159	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ABCB1—esophageal cancer	6.21e-05	0.000158	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTT1—esophageal cancer	6.19e-05	0.000158	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCND1—esophageal cancer	6.12e-05	0.000156	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.12e-05	0.000156	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	5.92e-05	0.000151	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	5.83e-05	0.000149	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	5.81e-05	0.000148	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.8e-05	0.000148	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ENO1—esophageal cancer	5.8e-05	0.000148	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	5.75e-05	0.000147	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	5.72e-05	0.000146	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSME1—esophageal cancer	5.72e-05	0.000146	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSME2—esophageal cancer	5.72e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	5.71e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—esophageal cancer	5.69e-05	0.000145	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	5.65e-05	0.000144	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EP300—esophageal cancer	5.63e-05	0.000144	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	5.47e-05	0.00014	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	5.45e-05	0.000139	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	5.4e-05	0.000138	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOS3—esophageal cancer	5.22e-05	0.000133	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOS3—esophageal cancer	5.2e-05	0.000133	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOS3—esophageal cancer	5.15e-05	0.000131	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	4.97e-05	0.000127	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	4.95e-05	0.000126	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.93e-05	0.000126	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MYC—esophageal cancer	4.91e-05	0.000125	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	4.9e-05	0.000125	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	4.88e-05	0.000124	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	4.86e-05	0.000124	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	4.82e-05	0.000123	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGFR—esophageal cancer	4.8e-05	0.000122	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—EP300—esophageal cancer	4.73e-05	0.000121	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.64e-05	0.000118	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCND1—esophageal cancer	4.31e-05	0.00011	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCND1—esophageal cancer	4.3e-05	0.00011	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCND1—esophageal cancer	4.25e-05	0.000109	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.23e-05	0.000108	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	4.17e-05	0.000106	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	4.17e-05	0.000106	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	4.16e-05	0.000106	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CREBBP—esophageal cancer	4.15e-05	0.000106	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	4.12e-05	0.000105	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.06e-05	0.000104	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TP53—esophageal cancer	4.03e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EP300—esophageal cancer	3.97e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EP300—esophageal cancer	3.95e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EP300—esophageal cancer	3.92e-05	9.99e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NOS3—esophageal cancer	3.72e-05	9.48e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CA—esophageal cancer	3.5e-05	8.92e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MYC—esophageal cancer	3.46e-05	8.82e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MYC—esophageal cancer	3.45e-05	8.79e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MYC—esophageal cancer	3.41e-05	8.7e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.4e-05	8.67e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGFR—esophageal cancer	3.38e-05	8.62e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGFR—esophageal cancer	3.37e-05	8.6e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGFR—esophageal cancer	3.34e-05	8.51e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	2.93e-05	7.48e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	2.93e-05	7.46e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	2.9e-05	7.39e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TP53—esophageal cancer	2.84e-05	7.24e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TP53—esophageal cancer	2.83e-05	7.22e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—EP300—esophageal cancer	2.83e-05	7.21e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TP53—esophageal cancer	2.8e-05	7.15e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.71e-05	6.92e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NOS3—esophageal cancer	2.43e-05	6.2e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.22e-05	5.67e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.09e-05	5.34e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—EP300—esophageal cancer	1.85e-05	4.72e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.37e-05	3.49e-05	CbGpPWpGaD
